About Silicon Biosystems
Silicon Biosystems is a company based in Bologna (Italy) founded in 1999 was acquired by Menarini in September 2013. Silicon Biosystems has raised $25.53 million across 3 funding rounds from investors including Innogest Capital and Menarini Group. Silicon Biosystems has completed 1 acquisition, including CellSearch. Silicon Biosystems offers products and services including CELLSEARCH, CellMag, and DEPArray. Silicon Biosystems operates in a competitive market with competitors including NanoCellect Biomedical, GenMark Diagnostics, Stilla Technologies, ThinkCyte and Cell Microsystems, among others.
- Headquarter Bologna, Italy
- SectorsHealthcare
- Website siliconbiosystems.com
- Social LinkedIn X YouTube
- Acquired by Menarini (Sep 2013)
- Legal Name Menarini Silicon Biosystems Spa
- Total Equity Funding$25.53M (USD)
in 3 rounds
- Latest Funding Round$15.98M (USD), Series C
Feb 2010
- InvestorsInnogest Capital
& 1 more
- Investments & Acquisitions
- Acquired byMenarini
(Sep 2013)
Products & Services of Silicon Biosystems
Silicon Biosystems offers a comprehensive portfolio of products and services, including CELLSEARCH, CellMag, and DEPArray.
Test for detecting circulating tumor cells in blood for cancer monitoring.
System for immunomagnetic enrichment of circulating tumor cells.
Technology for single cell isolation and molecular analysis.
Apps and channels of Silicon Biosystems
its YouTube channel Menarini Silicon Biosystems has 456 subscribers and 30 videos.
Videos from Silicon Biosystems
The most watched videos on Silicon Biosystems's YouTube channel, Menarini Silicon Biosystems (456 subscribers). Click a video to play it here.
More on Menarini Silicon Biosystems.
Funding Insights of Silicon Biosystems
Silicon Biosystems has successfully raised a total of $25.53M across 3 strategic funding rounds. The most recent funding activity was a Series C round of $15.98 million completed in February 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $25.53M
- Total Rounds 3
- Last Round Series C — $15.98M
- First Round $2.72M
(Jan 2007)
- Investors Count 1
All 3 funding rounds of Silicon Biosystems with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2010 | $15.98M | Series C | – | – | – |
| Mar 2007 | $6.83M | Series A | – | – | |
| Jan 2007 | $2.72M | Unspecified | – | – |
2 investors in total: 2 institutional.
Investors in Silicon Biosystems
Silicon Biosystems has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Innogest Capital and Menarini Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
VC firm investing in seed and early stage companies in Italy | – | innogestcapital.com | Milan, Italy | |
Menarini Group is engaged in pharmaceutical and healthcare solutions. | – | menarini.com | Florence, Italy |
Investor details for Silicon Biosystems
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Silicon Biosystems
59 people are tracked at Silicon Biosystems (17 in leadership, 42 in team).
| Name | Role | Group |
|---|---|---|
Daryl Spinner | Sr. Vice President, Market Access And Reimbursement | Leadership |
Stacey Verdino | Head Of Human Resources, US | Leadership |
Ralf Schoenbrunner | Chief Global R&d Officer | Leadership |
Deb N. | National Director-north America | Leadership |
Fabio Piazzalunga | President & Chief Executive Officer | Leadership |
Thomas Johnson | Vice President, Quality Assurance And Regulatory Affairs | Leadership |
Tom Hansen | Vice President Sales Marketing | Leadership |
Ana Aguilar | Chief Financial Officer CFO | Leadership |
Nicolò Manaresi | Founder CSO | Leadership |
Gianni Medoro | Chief Scientific Officer Chief Technology Officer | Leadership |
John Wineman | Vice President, Global Business Development | Leadership |
Raimo Tanzi | Chief Market Development Corporate | Leadership |
Richard del Mastro | Senior Director, R&d North America | Leadership |
Sara Lazaro | VP Of Operations & Site Manager | Leadership |
Anna Doffini | R&d Director | Leadership |
Christina Dorris | National Sales Director (interim) | Leadership |
Fan Wu | China Business Unit Head | Leadership |
Amy Wyscarver | Business Development Manager | Team |
Roberta Servino | Supply Chain Planning Specialist | Team |
Alyssa Talleur | Business Development Manager | Team |
39 more people are available in the full profile.
Complete people profiles for Silicon Biosystems
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Silicon Biosystems
Silicon Biosystems has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include CellSearch.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Circulating tumor cells are detected via specialized blood tests. | cellsearchctc.com | Raritan, United States | 2012 | Dec 2016 | •••• |
Complete acquisition details for Silicon Biosystems
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Silicon Biosystems
5 dated milestones of Silicon Biosystems across 17 years, from founding to its latest funding, stage changes and deals.
- Founded Silicon Biosystems is founded.
- Funding First funding round of $2.7M.
- Funding Latest funding round, Series C, of $16.0M.
- Exit Acquired by Menarini.
- Acquisition Acquires CellSearch.
Competitors of Silicon Biosystems
Silicon Biosystems operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as NanoCellect Biomedical, GenMark Diagnostics, Stilla Technologies, ThinkCyte and Cell Microsystems, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| nanocellect.com | 2009 | San Diego, United States | $78.15M | 84 | Develops flow cytometry and cell sorting technology | |
| genmarkdx.com | 1993 | San Diego, United States | $8.56M | 797 | Instruments and test panels for multiplexed molecular diagnostics are provided. | |
| stillatechnologies.com | 2013 | Villejuif, France | $53.11M | – | Digital PCR solutions for research are developed and analyzed. | |
| thinkcyte.com | 2016 | Bunkyo, Japan | $83.18M | – | Cell analysis and sorting technologies are developed with AI integration. | |
| cellmicrosystems.com | 2009 | Durham, United States | $19.1M | – | Developer of a technology to isolate and recover single cells for molecular analysis | |
| sense-bio.com | 2014 | Abingdon, United Kingdom | $79.22M | 43 | Provider of point of care molecular diagnostics solutions | |
| cytena.com | 2014 | – | $4.59M | 71 | Single cells are isolated using the cy-Clone device technology. | |
| singulex.com | 1997 | Alameda, United States | $140.94M | 236 | Single-molecule counting technology is developed for cardiovascular biomarker detection. | |
| lumacyte.com | 2012 | Charlottesville, United States | $24.05M | – | Provider of microfluidic and optics based instruments |
Detailed competitors of Silicon Biosystems
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Silicon Biosystems
Websites that share an audience with Silicon Biosystems (siliconbiosystems.com).
Websites whose visitors overlap most with Silicon Biosystems. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
ghimas.com | ghimas.com | 100% | – | #2,774,208 | – |
fagron.it | fagron.it | 100% | – | #8,979,446 | – |
gpnutraceuticals.com | gpnutraceuticals.com | 100% | – | #9,341,844 | – |
| fatro.it | 98% | 680.7K | #9,484,064 | View details | |
pluripharma.com | pluripharma.com | 97% | – | – | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 10 similar websites and full traffic analytics for Silicon Biosystems
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 10 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Silicon Biosystems
Complete news archive for Silicon Biosystems
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Silicon Biosystems
10 companies that operate in the same segment as Silicon Biosystems (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 265 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Silicon Biosystems
Silicon Biosystems was founded in 1999 and raised its 1st funding round 8 years after it was founded.
Silicon Biosystems is headquartered in Bologna, Italy. It is registered at Bologna, Emilia-romagna, Italy.
Silicon Biosystems is a funded company, having raised a total of $25.53M across 3 funding rounds to date. The company's 1st funding round was a Unspecified of $2.72M, raised on Jan 2007.
Silicon Biosystems was founded in 1999 in Bologna, Italy, within the biotechnology sector. Lab-on-a-chip solutions are created for cell-biology applications. DNA amplification from single cells is enabled by the Ampli1 whole genome kit. Cells are isolated using DEPArray technology based on dielectrophoresis. An automated DEPArray system is utilized for identifying and recovering rare cells, while Cell Browser software supports image-guided selection of specific cell populations.
Silicon Biosystems's top competitors include NanoCellect Biomedical, GenMark Diagnostics and ThinkCyte.
Silicon Biosystems offers CELLSEARCH, CellMag, and DEPArray.
Silicon Biosystems has made 1 acquisition, including CellSearch.
Silicon Biosystems has 2 investors. Key investors include Innogest Capital, and Menarini Group.
Silicon Biosystems operates through Menarini Silicon Biosystems Spa.
Yes. Silicon Biosystems was acquired by Menarini in September 2013.